BeOne Medicines (ONC) Operating Margin Growth (3y) (2018 - 2026)

BeOne Medicines (ONC) Operating Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -204.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 828,504.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 7,261.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -50,506.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -2,649.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,003.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 30,461.00
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -2.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7,261.00
Mar 31, 2026 9,942.00
Dec 31, 2025 13,564.00
Sep 30, 2025 12,464.00
Jun 30, 2025 13,532.00
Mar 31, 2025 14,556.00
Dec 31, 2024 -9,610.00
Sep 30, 2024 21,194.00
Jun 30, 2024 30,504.00
Mar 31, 2024 -4,635.00
Dec 31, 2023 42,393.00
Sep 30, 2023 46,610.00
Jun 30, 2023 49,323.00
Mar 31, 2023 63,504.00
Dec 31, 2022 55,877.00
Sep 30, 2022 50,969.00
Jun 30, 2022 -9,337.00
Mar 31, 2022 7,867.00
Dec 31, 2021 56,768.00
Sep 30, 2021 5,482.00